Halcón Resources Corporation (NYSE:HK) provided an operational update related to its 314,000 net acre position in the Tuscaloosa Marine Shale (“TMS”). The Horseshoe Hill 11-22H-1 (92% WI) well in Wilkinson County, Mississippi, achieved a 24-hour average initial production rate of 1,208 barrels of oil per day and 1.1 million cubic feet per day of 1,551 BTU natural gas on a 19/64 inch choke. Based on gas composition analysis and assuming full ethane recovery, the Company estimates that the well would produce an additional 212 barrels of NGLs per day for a total 24-hour average initial production rate of 1,548 barrels of oil equivalent per day. Halcon Resources Corp (NYSE:HK) stock opened today at $6.52and is currently trading at $6.52. The stock showed a positive weekly performance of 2.56%.
Dollar General Corp. (NYSE:DG) announced plans this week to expand its nationwide presence into three new states within the next year, increasing the company’s presence to 43 states across the country. The major discount retailer will begin construction on stores in Maine and Rhode Island this fall with plans to expand into Oregon in early 2015. Dollar General Corp. (NYSE:DG) stock opened at $63.43, in current trading session and currently is at $64.20, by gaining 10.54%. The 52 week range of the stock is $49.47 – $64.47. Company’s market capitalization is $19.47 billion.
Trade-Ideas LLC identified BioDelivery Sciences International Inc. (NASDAQ:BDSI) as a pre-market mover with heavy volume candidate. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) stock is currently trading at $10.12. The EPS of the stock is -1.28. Company’s market capitalization is $490.24 million.
Gilead Sciences, Inc. (NASDAQ:GILD) on June 3 announced updated interim results of a Phase 2 study (Study 102) evaluating GS-9973, its investigational oral inhibitor of spleen tyrosine kinase (Syk), for the treatment of patients with relapsed chronic lymphocytic leukemia (CLL). In this study, single-agent treatment with GS-9973 achieved an overall response rate of 49 percent, with an estimated progression-free survival (PFS) rate at 24 weeks of 70 percent. Detailed results will be presented today during an oral session at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Gilead Sciences, Inc. (NASDAQ:GILD) stock opened the session at $81.50, and now is at $80.88. The 52 week range of the stock remained $46.70 – $84.88 and the day range was $ 80.80 – $ 81.50.
Merck & Co. agreed to buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) in a bid to expand its portfolio of hepatitis C treatments. The pharmaceutical company said it will acquire Idenix for $24.50 a share in cash, more than three times Idenix’s closing price Friday. Idenix more than tripled to $24.11. Idenix Pharmaceuticals Inc (NASDAQ:IDIX) stock opened today at $24.01 and is currently trading at $23.92. The stock showed a positive weekly performance of 15.31%.